Magnus Söderberg CVRM Safety Safety, Clinical Pharmacology & Safety Sciences, R&D Biography Publications Institution JoVE Articles Magnus Söderberg has not added a biography. If you are Magnus Söderberg and would like to personalize this page please email our Author Liaison for assistance. Publications Urinary Kidney Biomarker Panel Detects Preclinical Antisense Oligonucleotide-Induced Tubular Toxicity Toxicologic Pathology. 12, 2020 | Pubmed ID: 33084520 The Regulatory Role of PGC1α-related Coactivator in Response to Drug-induced Liver Injury FASEB BioAdvances. Aug, 2020 | Pubmed ID: 32821877 "Dysmorphic" Lysosomes in Proximal Tubular Cells Are Not Specific for CINAC/CKDu and Do Not Provide Evidence That CINAC/CKDu is a Toxin-induced Disease Kidney International. 09, 2020 | Pubmed ID: 32565190 Matrix Gla Protein is an Independent Predictor of Both Intimal and Medial Vascular Calcification in Chronic Kidney Disease Scientific Reports. 04, 2020 | Pubmed ID: 32313061 Functionality of Primary Hepatic Non-parenchymal Cells in a 3D Spheroid Model and Contribution to Acetaminophen Hepatotoxicity Archives of Toxicology. 04, 2020 | Pubmed ID: 32112222 Aortic Valve Calcium Associates with All-Cause Mortality Independent of Coronary Artery Calcium and Inflammation in Patients with End-Stage Renal Disease Journal of Clinical Medicine. Feb, 2020 | Pubmed ID: 32102408 Copeptin is Independently Associated with Vascular Calcification in Chronic Kidney Disease Stage 5 BMC Nephrology. 02, 2020 | Pubmed ID: 32033584 High-protein Diet Accelerates Diabetes and Kidney Disease in the BTBR Mouse American Journal of Physiology. Renal Physiology. 03, 2020 | Pubmed ID: 31961715 Reduced Skeletal Muscle Expression of Mitochondrial-derived Peptides Humanin and MOTS-C and Nrf2 in Chronic Kidney Disease American Journal of Physiology. Renal Physiology. 11, 2019 | Pubmed ID: 31432706 Response to Letter from Dr Oliviera in Relation to Our Publication: A Study in a Rat Initiation-promotion Bladder Tumour Model Demonstrated No Promoter/progressor Potential of Dapagliflozin Regulatory Toxicology and Pharmacology : RTP. 08, 2019 | Pubmed ID: 31095971 A Study in a Rat Initiation-promotion Bladder Tumour Model Demonstrated No Promoter/progressor Potential of Dapagliflozin Regulatory Toxicology and Pharmacology : RTP. Apr, 2019 | Pubmed ID: 30685222 Entrega direta de medicamentos ao rim através da artéria renal Ulrika Dahlqvist1, Tajana Tesan Tomic2, Magnus Söderberg3, Jane Stubbe4, Camilla Enggaard4, Anette Ericsson5, Alex-Xianghua Zhou1, Anna Björnson Granqvist1, Lena William-Olsson1 1Bioscience Renal, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, 2Cell/mol Pharmacology, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, 3CVRM Safety, Safety, Clinical Pharmacology & Safety Sciences, R&D, 4Department of Cardiovascular and Renal Research, University of Southern Denmark, 5Clinical Renal, Late-stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D JoVE 61932 의학
Entrega direta de medicamentos ao rim através da artéria renal Ulrika Dahlqvist1, Tajana Tesan Tomic2, Magnus Söderberg3, Jane Stubbe4, Camilla Enggaard4, Anette Ericsson5, Alex-Xianghua Zhou1, Anna Björnson Granqvist1, Lena William-Olsson1 1Bioscience Renal, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, 2Cell/mol Pharmacology, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, 3CVRM Safety, Safety, Clinical Pharmacology & Safety Sciences, R&D, 4Department of Cardiovascular and Renal Research, University of Southern Denmark, 5Clinical Renal, Late-stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D JoVE 61932 의학